Patents by Inventor Christoph Schumacher

Christoph Schumacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220363089
    Abstract: An abrasion-resistant wood-based panel having a top side and a bottom side, with at least one decorative layer arranged on the top side, in particular with a structure synchronous with the decoration, is disclosed herein.
    Type: Application
    Filed: August 2, 2022
    Publication date: November 17, 2022
    Inventors: Christoph Schumacher, Stefan Zick
  • Patent number: 11447491
    Abstract: The present invention relates to a compound selected from (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine and a pharmaceutically acceptable salt thereof, and in particular to the phosphate salt of (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine, both having preferably an enantiomeric excess of the (R) form higher than or equal to 97%. Furthermore, the present invention relates to pharmaceutical compositions comprising the same, their use as a medicament and in methods of treatment of diseases and disorders in humans including women of child bearing potential and pediatric patients in which aldosterone over-exposure contributes to the deleterious effects of said diseases or disorders, as well as processes for preparing said inventive compounds.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: September 20, 2022
    Assignee: DAMIAN PHARMA AG
    Inventors: Christoph Schumacher, Walter Fuhrer, Ronald Edward Steele
  • Patent number: 11440341
    Abstract: A method for producing an abrasion-resistant wood-based panel having a top side and a bottom side, with at least one decorative layer arranged on the top side, in particular with a structure synchronous with the decoration, is disclosed herein.
    Type: Grant
    Filed: January 8, 2020
    Date of Patent: September 13, 2022
    Assignee: Flooring Technologies Ltd.
    Inventors: Christoph Schumacher, Stefan Zick
  • Publication number: 20220234999
    Abstract: A process for preparing urea comprises preparing formamide based on carbon dioxide, hydrogen, and ammonia, forming methyl formate or ammonium formate as an intermediate in a catalytic reaction, and preparing urea by reacting the formamide and possibly ammonia in the presence of a catalyst. The source of carbon dioxide is a liquid laden with chemically and/or physically bound carbon dioxide and selected from a methanol phase or an aqueous ammonia solution obtained by gas scrubbing of a syngas for removing carbon dioxide using a scrubbing fluid. The scrubbing fluid can be a methanol phase, or carbon dioxide is desorbed from the scrubbing fluid and absorbed into a methanol phase to give a carbon dioxide-laden methanol phase that is then reacted as carbon dioxide-containing stream with a hydrogen-containing stream in the presence of a catalyst to form methyl formate. The methyl formate is reacted with an ammonia-containing stream to form formamide.
    Type: Application
    Filed: April 27, 2020
    Publication date: July 28, 2022
    Applicants: thyssenkrupp Industrial Solutions AG, thyssenkrupp AG
    Inventors: Yevgeny MAKHYNYA, Tarek EL HAWARY, Christoph GLOTZBACH, Nils TENHUMBERG, Walter LEITNER, Jürgen KLANKERMAYER, Hannah SCHUMACHER
  • Publication number: 20220219156
    Abstract: A ruthenium-phosphine complex can be used as a catalyst in a method for the catalytic synthesis of urea. The method may comprise more particularly a reaction of formamide or of formamide with ammonia in the presence of the catalyst to form urea and hydrogen. Through the use of the ruthenium-phosphine complex as the catalyst, catalytic preparation of urea from formamide or from formamide with ammonia is provided for the first time. This allows for synthesis under mild conditions and virtually no formation of byproducts. Further, using an acid as a cocatalyst in the catalytic synthesis or the reaction can lead to an improvement in urea yield.
    Type: Application
    Filed: April 27, 2020
    Publication date: July 14, 2022
    Applicants: thyssenkrupp Industrial Solutions AG, thyssenkrupp AG
    Inventors: Christoph GLOTZBACH, Nils TENHUMBERG, Tarek EL HAWARY, Yevgeny MAKHYNYA, Walter LEITNER, Jürgen KLANKERMAYER, Hannah SCHUMACHER
  • Publication number: 20220097445
    Abstract: A method for producing an abrasion-resistant wood-based panel having a top side and a bottom side, with at least one decorative layer arranged on the top side, in particular with a structure synchronous with the decoration, is disclosed herein.
    Type: Application
    Filed: January 8, 2020
    Publication date: March 31, 2022
    Inventors: Christoph Schumacher, Stefan Zick
  • Publication number: 20220081049
    Abstract: A lock system for securing a battery of a vehicle operable by muscle power and/or motor power, in particular an electric bicycle. The lock system includes: a deadbolt which is pivotable about a bolt axis, a lock cylinder which is configured to actuate the deadbolt, and a lifting element which is coupled to the lock cylinder, the lock cylinder being movable into a holding position and into a release position, the lock cylinder in the holding position preventing a removal of the battery in a removal direction, and in the release position allowing the removal of the battery. The lifting element is configured to move the battery in the removal direction when the deadbolt is moved from the holding position into the release position.
    Type: Application
    Filed: July 13, 2020
    Publication date: March 17, 2022
    Inventors: Christoph Schumacher, Dennis Mehlo, Haris Alisic, Lisa Bayer, Thilo Koeder, Volker Jabs, Frank Hummel
  • Patent number: 11135192
    Abstract: The present invention relates to the NEP inhibitor pro-drug N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester, or a pharmaceutically acceptable salt thereof; or the NEP inhibitor N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid, or a pharmaceutically acceptable salt thereof, pro-drug for use in the treatment, prevention or delay of progression of a disease characterized by atrial enlargement and/or remodeling; a method for treatment, prevention or delay of progression of a disease characterized by atrial enlargement and/or remodeling comprising administration of a therapeutically effective amount, or a prophylactically effective amount, of the NEP inhibitor or the NEP inhibitor pro-drug, or a pharmaceutically acceptable salt pro-drug thereof, to a subject, e.g. a human subject, in need of such treatment.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: October 5, 2021
    Assignee: Novartis AG
    Inventors: Christoph Schumacher, Thomas Holbro
  • Publication number: 20210213820
    Abstract: A retaining system which may be used for locking an energy store, in particular for an electrically operable two-wheeled vehicle. The retaining system is designed such that it does not transfer any forces from the energy store to the retaining system in the locked or latched position.
    Type: Application
    Filed: July 11, 2019
    Publication date: July 15, 2021
    Inventors: Christoph Schumacher, Dennis Mehlo, Haris Alisic, Thilo Koeder, Volker Jabs, Lisa Bayer
  • Publication number: 20210169861
    Abstract: The present invention relates to a composition for use in the treatment of a disease or disorder, wherein said disease or disorder is preferably a disease or disorder in which aldosterone overexposure contributes to the symptoms of said disease or disorder, said composition comprises a compound which is (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine or a pharmaceutically acceptable salt thereof, wherein preferably said compound is (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazolium[1,5-a]pyridine dihydrogen phosphate, and wherein said compound has an enantiomeric excess (ee) of the (R) form higher than or equal to 97%, and wherein said composition is administered once daily to a subject in need thereof.
    Type: Application
    Filed: May 2, 2019
    Publication date: June 10, 2021
    Inventors: Ronald Edward STEELE, Christoph SCHUMACHER
  • Patent number: 11024917
    Abstract: A retaining element provided for two-stage fastening to an accumulator or which is part of an accumulator, safeguards against removal from a retaining device. The retaining device is oriented toward the retaining element and is fastened in an interior of tubes of a bicycle frame of an electrically driven bicycle.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: June 1, 2021
    Assignee: Robert Bosch GmbH
    Inventors: Christian Trif, Christoph Schumacher, Frank Hummel, Martin Tenzer, Volker Jabs
  • Publication number: 20210024519
    Abstract: The present invention relates to a compound selected from (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine and a pharmaceutically acceptable salt thereof, and in particular to the phosphate salt of (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine, both having preferably an enantiomeric excess of the (R) form higher than or equal to 97%. Furthermore, the present invention relates to pharmaceutical compositions comprising the same, their use as a medicament and in methods of treatment of diseases and disorders in humans including women of child bearing potential and pediatric patients in which aldosterone over-exposure contributes to the deleterious effects of said diseases or disorders, as well as processes for preparing said inventive compounds.
    Type: Application
    Filed: August 12, 2020
    Publication date: January 28, 2021
    Inventors: Christoph SCHUMACHER, Walter FUHRER, Ronald Edward STEELE
  • Patent number: 10822332
    Abstract: The present invention relates to a compound selected from (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine and a pharmaceutically acceptable salt thereof, and in particular to the phosphate salt of (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine, both having preferably an enantiomeric excess of the (R) form higher than or equal to 97%. Furthermore, the present invention relates to pharmaceutical compositions comprising the same, their use as a medicament and in methods of treatment of diseases and disorders in humans including women of child bearing potential and pediatric patients in which aldosterone over-exposure contributes to the deleterious effects of said diseases or disorders, as well as processes for preparing said inventive compounds.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: November 3, 2020
    Assignee: DAMIAN PHARMA AG
    Inventors: Christoph Schumacher, Walter Fuhrer, Ronald Edward Steele
  • Patent number: 10549021
    Abstract: A pump having at least a fluid pump chamber (11) and a first driver chamber (12) separated from the fluid pump chamber (11) by an elastic wall (13, 13-1, 13-2) is described with the first driver chamber (12) expanding after a chemical reaction between fuel and oxidant and driving through deformation of the elastic wall fluid out of the fluid pump chamber (11), with the main parts of the pump being made of an elastic material to be used for example as a body implant.
    Type: Grant
    Filed: October 1, 2014
    Date of Patent: February 4, 2020
    Assignee: ETH Zurich
    Inventors: Wendelin Jan Stark, Christoph Schumacher, Roland Fuhrer, Michael Loepfe
  • Publication number: 20190292180
    Abstract: The present invention relates to a compound selected from (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine and a pharmaceutically acceptable salt thereof, and in particular to the phosphate salt of (R)-(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine, both having preferably an enantiomeric excess of the (R) form higher than or equal to 97%. Furthermore, the present invention relates to pharmaceutical compositions comprising the same, their use as a medicament and in methods of treatment of diseases and disorders in humans including women of child bearing potential and pediatric patients in which aldosterone over-exposure contributes to the deleterious effects of said diseases or disorders, as well as processes for preparing said inventive compounds.
    Type: Application
    Filed: October 26, 2017
    Publication date: September 26, 2019
    Applicant: DAMIAN PHARMA AG
    Inventors: Christoph SCHUMACHER, Walter FUHRER, Ronald Edward STEELE
  • Publication number: 20190165347
    Abstract: A retaining element provided for two-stage fastening to an accumulator or which is part of an accumulator, safeguards against removal from a retaining device. The retaining device is oriented toward the retaining element and is fastened in an interior of tubes of a bicycle frame of an electrically driven bicycle.
    Type: Application
    Filed: May 12, 2017
    Publication date: May 30, 2019
    Inventors: Christian Trif, Christoph Schumacher, Frank Hummel, Martin Tenzer, Volker Jabs
  • Patent number: D851039
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: June 11, 2019
    Assignee: Robert Bosch GmbH
    Inventor: Christoph Schumacher
  • Patent number: D882513
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: April 28, 2020
    Assignee: Robert Bosch GmbH
    Inventor: Christoph Schumacher
  • Patent number: D882514
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: April 28, 2020
    Assignee: Robert Bosch GmbH
    Inventor: Christoph Schumacher
  • Patent number: D882515
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: April 28, 2020
    Assignee: Robert Bosch GmbH
    Inventor: Christoph Schumacher